TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of task list steps completed in the absence of challenging behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Diagnostic agreement between the AI software and the ophthalmic examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Area Under the Curve (AUC(0 to 48hr)) for Alfuzosin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Alfuzosin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants to complete self-scar massage protocol as intended
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of daytime sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Intracranial clinical benefit rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Perioperative success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to non-anemic status in the last trimester of pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Low birth weight (<2500 grams) deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: 16SrRNA sequencing of vaginal secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Human Papillomavirus (HPV) viral integration test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Human Papillomavirus (HPV) genotyping tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to SNF-PCC Recommendations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post-operative day-1 morphine equivalent dose consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of mHealth intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appropriateness of intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dose of imatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of imatinib
Endpoint domain: Adverse events/effects
Primary endpoint: inspiratory endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent change from baseline in cerebrospinal fluid (CSF) heparan sulfate (HS) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the Vineland Adaptive Behavior Scale, Third Edition (Vineland-3)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Root apex healing status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximally tolerated dose (MTD) of papaverine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Muscles (PFM) Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of laparoscopic ALPPS
Endpoint domain: Adverse events/effects
Primary endpoint: Time Without Systemic Therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in Extracellular Volume (ECV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Defense and Veterans Pain Rating Score (DVPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Pain Inventory Scale (BPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life Satisfaction Questionnaire (LiSAT)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Assessment of olfactometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of thyroid dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum Pain Relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bite Force Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Antimicrobial Resistance (AMR) genetic determinants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HF Hospitalization Rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: 5 minute wheelchair running
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 Tesla Magnetic Resonance Imaging (MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited local and systemic Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Serious Adverse Events and Adverse Event of Special Interest
Endpoint domain: Adverse events/effects
Primary endpoint: Family dynamics
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Accuracy of MRE features for grading fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Win-ratio comparing treatment and control groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory Sinus Arrhythmia (RSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Remote Associates Test (RAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PASI 90 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Menorah Park Engagement Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of serious adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Serious Adverse Events (SAEs) and Non-SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Reporting Abnormal Hematology and Chemistry Parameters, Physical Examination, and Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Pain Intensity Using 0-100 Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progress Freesurvival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Geometric Mean Titers (GMTs) of SARS-CoV-2 Neutralizing Titers at 1 Month After Vaccination 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants with AE(s) leading to permanent study drug discontinuation, temporary study drug interruption, or study drug dose adjustment
Endpoint domain: Adverse events/effects
Primary endpoint: Vital signs (Blood Pressure and pulse)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnosis accuracy of TMJ disc displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivered ventilation frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Delivered ventilation volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time spent in moderate or vigorous activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of felt stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall Response rate as per IMWG by Investigator Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients that discontinue the study or have their surgery cancelled due to toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Nutrient deficiency in pregnant women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recent sexual activity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Maximum Tolerated Dose (MTD) of Oral Harmine HCl Based on Dose Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of precision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Technical Success Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frequency of use of meditation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of a wearable electroencephalographic (EEG) headband
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Impact of interactive meditation and sleep support
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: early quality of life changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Anesthesia dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcer Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: System-related complication free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of product related performance deficiencies per product or product group
Endpoint domain: Adverse events/effects
Primary endpoint: Composite endpoint of HbA1c <7.0% and ≥10% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve at steady-state (AUCss, 0-tau) of belimumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average serum concentration at steady state (Cavg, ss) of belimumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum serum concentrations at steady state (Cmin, ss) of belimumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum serum concentrations during the dosing interval at steady state (Cmax, ss) of belimumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foetal-maternal ratio of the drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of total elbow replacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Objective response rate (ORR) of neoadjuvant therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Net Promoter Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion spent in each marketplace
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: rate of premature discontinuation of the fasting-mimicking diet
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total bacterial load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to occurrence of breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Percent change in fasting TGs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: brain activation measured by functional magnetic resonance imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 6-minute walk distance (6MWD) difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage recovery of left ventricular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients reducing SYMBICORT® dose without loss of asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgesic Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual clarity on endoscope screen during shoulder arthroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postoperative course of shoulder arthroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from randomisation to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Respiratory muscular strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Invasive Breast Cancer-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Waitlist-status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Investigator's Global Assessment (IGA) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Eczema Area and Severity Index (EASI) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Oriented Eczema Measure (POEM) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Amyloid-β accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lesion biopsy rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: breast cancer detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: reduction of postoperative sequelae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time-Normalized Number of Investigator-Confirmed HAE Attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency Department visits within six weeks postpartum
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mitral valve repair failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1-year reoccurrence of mitral regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vascular bleeding event rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Nausea Score at 30 Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Nausea Score at 10 Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Nausea Score at Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local Disease Control Rate (LDCR) at 16 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Step Tracking Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diary of Steps Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Return Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Data Retrieval Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Infant Behavior Questionnaire-Revised (IBQ-R) Orienting/Regulation Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Auditory Sensory Gating (P50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: idiopathic normal pressure hydrocephalus (iNPH) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Salivary melatonin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of participants completing the study protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of study participants with a score of less than 45 on the PROMIS Physical Function Custom Form
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Change in PTSD diagnostic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in safety aid usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in neuronal coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Food preference for high energy dense foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Residual myeloma cell number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: DNA and EGFR mutation detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Urine levels of angiotensinogen-melatonin-creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to CR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extremity examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extracellular myocardial volume (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left atrial volume (ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal voluntary isometric peroneal contraction force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biodex Strength performance change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise Stages of Change Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-reported Drug Effect ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complication rate during cataract surgery
Endpoint domain: Adverse events/effects
Primary endpoint: VO2 max prediction scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse beat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acetabular cup antiversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acetabular cup inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Femoral offset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acetabular offset
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Eccentric Reaming
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in a momentary emotional state
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in thought believability and discomfort after engaging in CD exercise
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: average gate speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery-40 score (QoR-40)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of treatment-emergent adverse events (TEAE) grade 3 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: rate of change of vascular and non-vascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in 5-HT4R brain binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of COVID-19 Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With IV Access at First Attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in glycemic control as indexed by continuous glucose monitoring (CGM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in glycemic control as indexed by hemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in eating disorder symptoms as indexed by the Eating Disorder Examination Global score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in eating disorder symptoms as indexed by the Diabetes Eating Problems Survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in diabetes self-management as indexed by the Diabetes Self-Management Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Radiological evidence of intracranial arterial stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Differences in Immune profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in balance (Berg Balance Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional mobility (Timed Up and Go)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional mobility (Timed Up and Go Cognitive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in balance (One leg stance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global proportion of patient stays appropriate regarding health cares
Endpoint domain: Resource use
Endpoint subdomain: Other resource use